ANDAORALTABLET, EXTENDED RELEASE
Approved
Apr 2010
Lifecycle
Post-LOE
Competitive Pressure
60/100
Mechanism of Action
extended-release tablets is an antibacterial drug [see Microbiology ( )].
Indications (14)
infections in adultsequal to 40 kg• acute bacterial sinusitis due to confirmedsuspected β-lactamase-producing pathogens (iinfections due to Sdevelopment of drug-resistant bacteriamaintain the effectiveness of amoxicillinclavulanate potassium extended-release tabletsother antibacterial drugsamoxicillinclavulanate potassium extended-release tablets should be used only to treatprevent infectionsstrongly suspected to be caused by susceptible bacteriastrongly suspected to be caused by bacteria